CMS contracted Easton, Md.-based Health Integrity to investigate the $124 billion Medicare Advantage program, or Part C, and the prescription drug benefit, Part D. The OIG found 79 percent of Health Integrity’s nearly 2,300 fraud-finding investigations between 2010 and 2011 focused on Part D compared with 8 percent toward Part C.
Health Integrity shifted blame for its lopsided attention to CMS, which doesn’t grant the company access to Medicare Advantage’s central claims database to use for investigations, according to the report. Additionally, Health Integrity said unless law enforcement agrees to take on fraud cases, it lacks the authority to proceed with investigations.
More Articles on Medicare Advantage:
Commonwealth Fund: 10 Policies That Can Stabilize Healthcare Spending
District Court Orders HHS to Recalculate Medicare DSH Payments
Where Medicare Stands: A Discussion With Dr. Oliver Fein of Weill Cornell Medical College
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit